BG100068A - Method of detecting the presence of and converting of a polypeptide - Google Patents
Method of detecting the presence of and converting of a polypeptideInfo
- Publication number
- BG100068A BG100068A BG100068A BG10006895A BG100068A BG 100068 A BG100068 A BG 100068A BG 100068 A BG100068 A BG 100068A BG 10006895 A BG10006895 A BG 10006895A BG 100068 A BG100068 A BG 100068A
- Authority
- BG
- Bulgaria
- Prior art keywords
- growth hormone
- polypeptide
- converting
- detecting
- mercaptan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/61—Growth hormones [GH] (Somatotropin)
Abstract
По метода хидрофобно производно на растежния хормон може да бъде открито чрез хидрофобна хроматография и елуиране с амониев сулфат в качеството на градиент, последвано от пептидно картиране. Производното може да бъде третирано с меркаптаново съединение за превръщането му в нативна форма на растежния хормон. За предпочитане е растежният хормон да бъде човешки, а меркаптановото съединение цистеин вконцентрация 1-2 мм.By the hydrophobic growth hormone derivative method, it can be detected by hydrophobicity chromatography and eluting with ammonium sulfate as a gradient followed by peptide mapping. The derivative can be treated with a mercaptan compound to convert it into a native form of growth hormone. Preferably, the growth hormone is human, and the mercaptan cysteine compound at a concentration of 1-2 mm.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK93445A DK44593D0 (en) | 1993-04-20 | 1993-04-20 | PROCEDURE FOR PREPARING A POLYPEPTIDE |
PCT/DK1994/000157 WO1994024157A1 (en) | 1993-04-20 | 1994-04-19 | A method of detecting the presence of and converting of a polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
BG100068A true BG100068A (en) | 1996-12-31 |
Family
ID=8093625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG100068A BG100068A (en) | 1993-04-20 | 1995-10-17 | Method of detecting the presence of and converting of a polypeptide |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0695310A1 (en) |
JP (1) | JPH08508735A (en) |
KR (1) | KR960701891A (en) |
AU (1) | AU6535594A (en) |
BG (1) | BG100068A (en) |
CA (1) | CA2160663A1 (en) |
CZ (1) | CZ272895A3 (en) |
DK (1) | DK44593D0 (en) |
FI (1) | FI955000A0 (en) |
HU (1) | HUT73320A (en) |
IL (1) | IL109347A0 (en) |
NO (1) | NO954181D0 (en) |
PL (1) | PL311198A1 (en) |
WO (1) | WO1994024157A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9802454D0 (en) | 1998-07-08 | 1998-07-08 | Pharmacia & Upjohn Ab | Production of peptides |
US20040048315A1 (en) * | 2002-08-28 | 2004-03-11 | Pharmacia Corporation | Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
CN1697839B (en) * | 2002-08-28 | 2010-10-27 | 法玛西亚公司 | Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
ZA200502320B (en) * | 2002-09-20 | 2006-10-25 | Pharmacia Corp | Process for decreasing aggregate levels of pegylated protein |
SI1545428T1 (en) * | 2002-09-20 | 2010-03-31 | Pharmacia Corp | Process for decreasing aggregate levels of pegylated protein |
EP1833841B1 (en) | 2004-12-29 | 2010-04-07 | Novo Nordisk Health Care AG | Method for preventing formation of trisulfide derivatives of polypeptides |
US9005926B2 (en) | 2009-10-02 | 2015-04-14 | Biogen Idec Ma Inc. | Methods of preventing and removing trisulfide bonds |
US9562252B2 (en) | 2011-05-13 | 2017-02-07 | Biogen Ma Inc. | Methods of preventing and removing trisulfide bonds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4985544A (en) * | 1987-08-04 | 1991-01-15 | Kyowa Hakko Kogyo Co., Ltd. | Process for renaturing fish growth hormone |
US5079230A (en) * | 1988-09-12 | 1992-01-07 | Pitman-Moore, Inc. | Stable bioactive somatotropins |
WO1992004382A1 (en) * | 1990-09-05 | 1992-03-19 | Bunge (Australia) Pty. Ltd. | Solubilization of proteins in active forms |
US5151501A (en) * | 1991-12-20 | 1992-09-29 | American Cyanamid Company | Method for solubilization and naturation of somatotropins utilizing sulfolane |
-
1993
- 1993-04-20 DK DK93445A patent/DK44593D0/en not_active Application Discontinuation
-
1994
- 1994-04-19 CA CA002160663A patent/CA2160663A1/en not_active Abandoned
- 1994-04-19 CZ CZ952728A patent/CZ272895A3/en unknown
- 1994-04-19 JP JP6522643A patent/JPH08508735A/en active Pending
- 1994-04-19 IL IL10934794A patent/IL109347A0/en unknown
- 1994-04-19 PL PL94311198A patent/PL311198A1/en unknown
- 1994-04-19 HU HU9503020A patent/HUT73320A/en unknown
- 1994-04-19 WO PCT/DK1994/000157 patent/WO1994024157A1/en not_active Application Discontinuation
- 1994-04-19 EP EP94913048A patent/EP0695310A1/en not_active Withdrawn
- 1994-04-19 AU AU65355/94A patent/AU6535594A/en not_active Abandoned
- 1994-04-19 KR KR1019950704477A patent/KR960701891A/en not_active Application Discontinuation
-
1995
- 1995-10-17 BG BG100068A patent/BG100068A/en unknown
- 1995-10-19 FI FI955000A patent/FI955000A0/en not_active Application Discontinuation
- 1995-10-19 NO NO954181A patent/NO954181D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ272895A3 (en) | 1996-03-13 |
IL109347A0 (en) | 1994-07-31 |
NO954181L (en) | 1995-10-19 |
DK44593D0 (en) | 1993-04-20 |
CA2160663A1 (en) | 1994-10-27 |
FI955000A (en) | 1995-10-19 |
HUT73320A (en) | 1996-07-29 |
NO954181D0 (en) | 1995-10-19 |
EP0695310A1 (en) | 1996-02-07 |
WO1994024157A1 (en) | 1994-10-27 |
AU6535594A (en) | 1994-11-08 |
FI955000A0 (en) | 1995-10-19 |
JPH08508735A (en) | 1996-09-17 |
PL311198A1 (en) | 1996-02-05 |
KR960701891A (en) | 1996-03-28 |
HU9503020D0 (en) | 1995-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3686654D1 (en) | METHOD FOR ISOLATING RECOMBINANT POLYPEPTIDES IN BIOLOGICALLY ACTIVE FORM. | |
KR900013979A (en) | Immunogenic Regions of the Human Papillomavirus Type 16 E7 Protein | |
OA08762A (en) | Peptides for the diagnosis of HTLV-III antibodies, their preparation and use. | |
NO894503L (en) | URETANE-PROTECTED AMINO ACID-N-CARBOXYAN HYDRIDS. | |
ES2087323T3 (en) | METHOD FOR PRODUCING CYSTEINE-FREE PEPTIDES. | |
ATE92634T1 (en) | PROCEDURE FOR THE DETERMINATION OF A PROTEIN ACCORDING TO THE PRINCIPLE OF FLUORESCENCE POLARIZATION IMMUNOASSAY. | |
BG100068A (en) | Method of detecting the presence of and converting of a polypeptide | |
DK357880A (en) | METHOD OF CLEANING HUMAN GROWTH HORMON | |
FI903464A0 (en) | FOERFARANDE FOER OXIDERANDE DENATURERING AV PROTEINANALYTER. | |
ES2090273T3 (en) | CASE FOR THE SPECIFIC DOSAGE OF ANGIOTENSIN II. | |
DE69131579T2 (en) | SYNTHETIC ANTIGING OF AN AGING CELL | |
ES8700272A1 (en) | Process for the preparation and purification of peptides. | |
ATE167301T1 (en) | GROUP OF SEPARATE PEPTIDES | |
DE69034254D1 (en) | A-PDGF RECEPTOR AND ITS USE | |
NO900758D0 (en) | PROCEDURE FOR THE PREPARATION OF HYBRID PROTEIN. | |
NO173831C (en) | New monoclonal antibodies to IFN-omega, hybridomas for their preparation and use for purification, as well as the detection or quantitative determination of IFN-omega, and seen for use in the detection | |
FI863673A (en) | D-AMINOSYREOXIDE SAMT FOERFARANDE FOER DESS ISOLERING. | |
EP0502553A3 (en) | Peptide fragment from human villin and antibody thereto | |
DK447784D0 (en) | immune | |
ATE129744T1 (en) | RECOMBINANT C-TERMINAL ALPHA AMIDATING ENZYME OF HUMAN THYROID ORIGIN. | |
ATE163652T1 (en) | ANTIBODIES TO THE CARBOXY-TERMINAL PEPTIDE OF THE RAT SOMATOTROPIN BINDING PROTEIN | |
Cox et al. | Disulfide interchange reactions between cystamine and cystine peptides | |
ES476780A3 (en) | Procedure for preparing a polypeptide capable of reducing the levels of calcium in the blood, and a salt of acid addition or complex thereof. (Machine-translation by Google Translate, not legally binding) |